← Leaderboards
Matthew Petroski
Sanford Burnham Prebys Medical Discovery Institute
$4,226,279
Attributed
$4,226,279
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2012–17$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$4,226,279 · 4
By mechanism
R01$3,663,703 · 2
R21$466,538 · 1
R03$96,038 · 1
Top collaborators
No co-investigators on record.
Most similar at Sanford Burnham Prebys Medical Discovery Institute
Same institution · by research overlap
- Michal Sharon$420,886
Others in their field
Top investigators on “Enzymes”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Randall J Bateman · Washington University$83,824,814
- Stuart L Schreiber · Harvard University (Medical School)$49,424,554
- Jay D Keasling · University Of California-Berkeley$47,558,861
- David Heimbrook · Leidos Biomedical Research, Inc.$47,513,682
- Susan Abushakra · Alzheon, Inc.$47,265,244
Research focus
EnzymesCancer CellMalignant NeoplasmsResponseBaseInnovationPre-ClinicalPharmaceutical PreparationsMutationEnzyme Inhibitor DrugsEnzyme ActivityEnzyme InhibitionAffinityCancer PatientResistanceEnzyme InhibitorsCancer TherapyBiologicalIn VivoPreventEquilibriumAdverse EffectsPhase I Clinical TrialsDrug Targeting
Grant awards (12)
Assay Development for the Identification of NEDD8- activating Enzyme Inhibitors$446,063
R01 · FY2017 · CA · contact PI
(PQD1) Treatment-emergent resistance to NEDD8-activating enzyme inhibition$558,328
R01 · FY2016 · CA · contact PI
Assay Development for the Identification of NEDD8- activating Enzyme Inhibitors$446,063
R01 · FY2016 · CA · contact PI
(PQD1) Treatment-emergent resistance to NEDD8-activating enzyme inhibition$558,328
R01 · FY2015 · CA · contact PI
Assay Development for the Identification of NEDD8- activating Enzyme Inhibitors$446,063
R01 · FY2015 · CA · contact PI
Characterization and suppression of resistance to NEDD8 E1 inhibition$212,063
R21 · FY2015 · CA · contact PI
(PQD1) Treatment-emergent resistance to NEDD8-activating enzyme inhibition$541,578
R01 · FY2014 · CA · contact PI
Characterization and suppression of resistance to NEDD8 E1 inhibition$254,475
R21 · FY2014 · CA · contact PI
(PQD1) Treatment-emergent resistance to NEDD8-activating enzyme inhibition$108,952
R01 · FY2014 · CA · contact PI
(PQD1) Treatment-emergent resistance to NEDD8-activating enzyme inhibition$558,328
R01 · FY2013 · CA · contact PI
High throughput screening for modulators of UBC12$47,288
R03 · FY2013 · DA · contact PI
High throughput screening for modulators of UBC12$48,750
R03 · FY2012 · DA · contact PI